Kexing Biopharm Co., Ltd. (SHA:688136)

Kexing Biopharm Revenue

Kexing Biopharm had revenue of 326.60M CNY in the quarter ending June 30, 2026, a decrease of -5.85%. This brings the company's revenue in the last twelve months to 1.44B, up 6.92% year-over-year. In the year 2025, Kexing Biopharm had annual revenue of 1.53B with 9.03% growth.

• Revenue (ttm): 1.44B
• Revenue Growth: +6.92%
• P/S Ratio: 2.91
• Revenue / Employee: 1.37M
• Employees: 1,048
• Market Cap: 4.19B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.53B	127.10M	9.03%
Dec 31, 2024	1.41B	147.89M	11.75%
Dec 31, 2023	1.26B	-56.84M	-4.32%
Dec 31, 2022	1.32B	30.70M	2.39%
Dec 31, 2021	1.29B	64.88M	5.32%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error